Correction: FDA Office Of Women’s Health
This article was originally published in The Pink Sheet Daily
Executive Summary
The first major undertaking for new FDA Assistant Commissioner for Science Linda Tollefson under her duties as head of FDA's Office of Women's Health is likely to be responding to the agency's decision on the over-the-counter switch application for Barr's Plan B contraceptive